Skip to content

Hannah Zhao

2 papers in the library · 14 citations · publishing 2021-2022

Papers

Pharmacological modelling of dissociation and psychosis: an evaluation of the Clinician Administered Dissociative States Scale and Psychotomimetic States Inventory during nitrous oxide (‘laughing gas’)-induced anomalous states

Psychopharmacology March 26, 2022 Giulia Piazza, G. Iskandar, V. Hennessy et al. 14 citations

Nitrous oxide (N2O) produces dissociative and psychosis-like effects comparable to those of ketamine in healthy volunteers, making it a practical alternative for modeling these experiences outside clinical settings. Analysis of data from three previous studies found that the Clinician Administered Dissociative States Scale (CADSS) and Psychotomimetic States Inventory (PSI) capture largely non-overlapping subjective experiences during N2O inhalation. A three-factor model of dissociation was confirmed, though a two-factor model may be more parsimonious. Psychosis-like symptoms were represented by two negative and two positive symptom factors. The findings suggest both measures should be used together to comprehensively assess anomalous states from dissociative NMDAR antagonists.

Rewarding Subjective Effects of the NMDAR Antagonist Nitrous Oxide (Laughing Gas) Are Moderated by Impulsivity and Depressive Symptoms in Healthy Volunteers.

The international journal of neuropsychopharmacology July 23, 2021 Sunjeev K Kamboj, Hannah Zhao, Luzia Troebinger et al.

Nitrous oxide (N2O), an anesthetic gas that blocks NMDA receptors, produces subjective rewarding effects similar to those of moderate-dose ketamine. Healthy volunteers randomly assigned to inhale 50% N2O reported liking and wanting effects comparable in size to those seen with ketamine. Impulsivity increased how much participants liked N2O, while depressive symptoms decreased how much they wanted more. These opposite directional influences suggest impulsivity may predispose and depression may protect against N2O abuse. N2O may serve as a safe substitute for ketamine in studying reward-related NMDA receptor function in humans.